nodes	percent_of_prediction	percent_of_DWPC	metapath
Bepridil—CALM2—semen—testicular cancer	0.0271	0.0762	CbGeAlD
Bepridil—CALM1—semen—testicular cancer	0.027	0.0758	CbGeAlD
Bepridil—ABCB1—Dactinomycin—testicular cancer	0.025	0.223	CbGbCtD
Bepridil—ABCB1—Vinblastine—testicular cancer	0.0156	0.14	CbGbCtD
Bepridil—CYP2D6—Vinblastine—testicular cancer	0.0147	0.132	CbGbCtD
Bepridil—ABCB1—Cisplatin—testicular cancer	0.0143	0.128	CbGbCtD
Bepridil—ABCB1—Etoposide—testicular cancer	0.0141	0.126	CbGbCtD
Bepridil—KCNQ1—seminal vesicle—testicular cancer	0.0137	0.0384	CbGeAlD
Bepridil—PDE1B—gonad—testicular cancer	0.0127	0.0356	CbGeAlD
Bepridil—CACNA1H—seminal vesicle—testicular cancer	0.0115	0.0322	CbGeAlD
Bepridil—PDE1A—gonad—testicular cancer	0.0106	0.0298	CbGeAlD
Bepridil—CACNA1A—testis—testicular cancer	0.0105	0.0294	CbGeAlD
Bepridil—ABCB1—Doxorubicin—testicular cancer	0.00961	0.086	CbGbCtD
Bepridil—ABCB1—Methotrexate—testicular cancer	0.00931	0.0833	CbGbCtD
Bepridil—PDE1B—testis—testicular cancer	0.00913	0.0257	CbGeAlD
Bepridil—CYP2D6—Doxorubicin—testicular cancer	0.00906	0.081	CbGbCtD
Bepridil—TNNC1—testis—testicular cancer	0.00875	0.0246	CbGeAlD
Bepridil—PDE1A—female gonad—testicular cancer	0.00863	0.0242	CbGeAlD
Bepridil—CACNA1H—gonad—testicular cancer	0.00829	0.0233	CbGeAlD
Bepridil—KCNQ1—female gonad—testicular cancer	0.00802	0.0225	CbGeAlD
Bepridil—PDE1A—testis—testicular cancer	0.00765	0.0215	CbGeAlD
Bepridil—CACNA2D2—testis—testicular cancer	0.00736	0.0207	CbGeAlD
Bepridil—CALM3—seminal vesicle—testicular cancer	0.00732	0.0206	CbGeAlD
Bepridil—KCNQ1—testis—testicular cancer	0.00711	0.02	CbGeAlD
Bepridil—ATP1A1—embryo—testicular cancer	0.00695	0.0195	CbGeAlD
Bepridil—CACNA1H—female gonad—testicular cancer	0.00673	0.0189	CbGeAlD
Bepridil—PDE1B—lymph node—testicular cancer	0.00662	0.0186	CbGeAlD
Bepridil—ATP1A1—seminal vesicle—testicular cancer	0.00653	0.0183	CbGeAlD
Bepridil—TNNC1—lymph node—testicular cancer	0.00634	0.0178	CbGeAlD
Bepridil—CALM2—embryo—testicular cancer	0.00612	0.0172	CbGeAlD
Bepridil—CALM1—embryo—testicular cancer	0.00609	0.0171	CbGeAlD
Bepridil—CACNA1H—testis—testicular cancer	0.00597	0.0168	CbGeAlD
Bepridil—CALM2—seminal vesicle—testicular cancer	0.00575	0.0162	CbGeAlD
Bepridil—PDE1A—lymph node—testicular cancer	0.00555	0.0156	CbGeAlD
Bepridil—CACNA2D2—lymph node—testicular cancer	0.00534	0.015	CbGeAlD
Bepridil—KCNH2—seminal vesicle—testicular cancer	0.00521	0.0146	CbGeAlD
Bepridil—KCNQ1—lymph node—testicular cancer	0.00516	0.0145	CbGeAlD
Bepridil—CACNA1D—testis—testicular cancer	0.00493	0.0139	CbGeAlD
Bepridil—ATP1A1—gonad—testicular cancer	0.00472	0.0133	CbGeAlD
Bepridil—CACNA1C—testis—testicular cancer	0.00455	0.0128	CbGeAlD
Bepridil—CACNA1H—lymph node—testicular cancer	0.00433	0.0122	CbGeAlD
Bepridil—CALM3—female gonad—testicular cancer	0.0043	0.0121	CbGeAlD
Bepridil—CALM2—gonad—testicular cancer	0.00415	0.0117	CbGeAlD
Bepridil—CALM1—gonad—testicular cancer	0.00413	0.0116	CbGeAlD
Bepridil—ATP1A1—female gonad—testicular cancer	0.00383	0.0108	CbGeAlD
Bepridil—CALM3—testis—testicular cancer	0.00381	0.0107	CbGeAlD
Bepridil—CACNA1D—lymph node—testicular cancer	0.00357	0.01	CbGeAlD
Bepridil—ATP1A1—testis—testicular cancer	0.0034	0.00955	CbGeAlD
Bepridil—CALM2—female gonad—testicular cancer	0.00337	0.00948	CbGeAlD
Bepridil—CALM1—female gonad—testicular cancer	0.00336	0.00944	CbGeAlD
Bepridil—CACNA1C—lymph node—testicular cancer	0.0033	0.00927	CbGeAlD
Bepridil—KCNH2—female gonad—testicular cancer	0.00306	0.00859	CbGeAlD
Bepridil—CALM2—testis—testicular cancer	0.00299	0.00841	CbGeAlD
Bepridil—CALM1—testis—testicular cancer	0.00298	0.00837	CbGeAlD
Bepridil—CALM3—lymph node—testicular cancer	0.00276	0.00776	CbGeAlD
Bepridil—KCNH2—testis—testicular cancer	0.00271	0.00762	CbGeAlD
Bepridil—ATP1A1—lymph node—testicular cancer	0.00246	0.00692	CbGeAlD
Bepridil—ABCB1—embryo—testicular cancer	0.00243	0.00683	CbGeAlD
Bepridil—ABCB1—seminal vesicle—testicular cancer	0.00228	0.00642	CbGeAlD
Bepridil—CALM2—lymph node—testicular cancer	0.00217	0.0061	CbGeAlD
Bepridil—CALM1—lymph node—testicular cancer	0.00216	0.00607	CbGeAlD
Bepridil—KCNH2—lymph node—testicular cancer	0.00197	0.00552	CbGeAlD
Bepridil—CYP2D6—female gonad—testicular cancer	0.00186	0.00524	CbGeAlD
Bepridil—CYP2D6—testis—testicular cancer	0.00165	0.00465	CbGeAlD
Bepridil—ABCB1—gonad—testicular cancer	0.00165	0.00464	CbGeAlD
Bepridil—Decreased appetite—Vinblastine—testicular cancer	0.00152	0.00504	CcSEcCtD
Bepridil—Body temperature increased—Chlorambucil—testicular cancer	0.00151	0.005	CcSEcCtD
Bepridil—Abdominal pain—Chlorambucil—testicular cancer	0.00151	0.005	CcSEcCtD
Bepridil—Constipation—Vinblastine—testicular cancer	0.0015	0.00496	CcSEcCtD
Bepridil—Pain—Vinblastine—testicular cancer	0.0015	0.00496	CcSEcCtD
Bepridil—Oedema—Bleomycin—testicular cancer	0.00148	0.0049	CcSEcCtD
Bepridil—Vision blurred—Ifosfamide—testicular cancer	0.00146	0.00483	CcSEcCtD
Bepridil—Ventricular tachycardia—Doxorubicin—testicular cancer	0.00145	0.00481	CcSEcCtD
Bepridil—Myalgia—Dactinomycin—testicular cancer	0.00144	0.00477	CcSEcCtD
Bepridil—Gastrointestinal pain—Vinblastine—testicular cancer	0.00143	0.00474	CcSEcCtD
Bepridil—Tinnitus—Cisplatin—testicular cancer	0.00143	0.00474	CcSEcCtD
Bepridil—Cardiac disorder—Cisplatin—testicular cancer	0.00142	0.00471	CcSEcCtD
Bepridil—Anorexia—Bleomycin—testicular cancer	0.00141	0.00467	CcSEcCtD
Bepridil—Vertigo—Ifosfamide—testicular cancer	0.00139	0.00461	CcSEcCtD
Bepridil—Abdominal pain—Vinblastine—testicular cancer	0.00138	0.00458	CcSEcCtD
Bepridil—Oedema—Dactinomycin—testicular cancer	0.00138	0.00457	CcSEcCtD
Bepridil—Asthenia—Chlorambucil—testicular cancer	0.00137	0.00454	CcSEcCtD
Bepridil—Arrhythmia—Cisplatin—testicular cancer	0.00137	0.00454	CcSEcCtD
Bepridil—Palpitations—Ifosfamide—testicular cancer	0.00137	0.00453	CcSEcCtD
Bepridil—Cough—Ifosfamide—testicular cancer	0.00135	0.00448	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Bleomycin—testicular cancer	0.00135	0.00446	CcSEcCtD
Bepridil—ABCB1—female gonad—testicular cancer	0.00134	0.00377	CbGeAlD
Bepridil—Hypertension—Ifosfamide—testicular cancer	0.00134	0.00443	CcSEcCtD
Bepridil—Paraesthesia—Bleomycin—testicular cancer	0.00133	0.0044	CcSEcCtD
Bepridil—Dyspnoea—Bleomycin—testicular cancer	0.00132	0.00437	CcSEcCtD
Bepridil—Myalgia—Ifosfamide—testicular cancer	0.00132	0.00437	CcSEcCtD
Bepridil—Flatulence—Cisplatin—testicular cancer	0.00131	0.00436	CcSEcCtD
Bepridil—Anorexia—Dactinomycin—testicular cancer	0.00131	0.00435	CcSEcCtD
Bepridil—Diarrhoea—Chlorambucil—testicular cancer	0.00131	0.00433	CcSEcCtD
Bepridil—Cardiac disorder—Etoposide—testicular cancer	0.0013	0.00432	CcSEcCtD
Bepridil—Decreased appetite—Bleomycin—testicular cancer	0.00128	0.00426	CcSEcCtD
Bepridil—Pain—Bleomycin—testicular cancer	0.00126	0.00419	CcSEcCtD
Bepridil—Oedema—Ifosfamide—testicular cancer	0.00126	0.00419	CcSEcCtD
Bepridil—Vision blurred—Cisplatin—testicular cancer	0.00126	0.00417	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Dactinomycin—testicular cancer	0.00126	0.00416	CcSEcCtD
Bepridil—Asthenia—Vinblastine—testicular cancer	0.00126	0.00416	CcSEcCtD
Bepridil—Tremor—Cisplatin—testicular cancer	0.00125	0.00414	CcSEcCtD
Bepridil—Hyperhidrosis—Ifosfamide—testicular cancer	0.00122	0.00405	CcSEcCtD
Bepridil—Increased appetite—Epirubicin—testicular cancer	0.00121	0.00401	CcSEcCtD
Bepridil—Anorexia—Ifosfamide—testicular cancer	0.0012	0.00399	CcSEcCtD
Bepridil—Decreased appetite—Dactinomycin—testicular cancer	0.0012	0.00397	CcSEcCtD
Bepridil—Diarrhoea—Vinblastine—testicular cancer	0.0012	0.00397	CcSEcCtD
Bepridil—ABCB1—testis—testicular cancer	0.00119	0.00334	CbGeAlD
Bepridil—Pain—Dactinomycin—testicular cancer	0.00118	0.00391	CcSEcCtD
Bepridil—Body temperature increased—Bleomycin—testicular cancer	0.00117	0.00387	CcSEcCtD
Bepridil—Cardiac failure—Epirubicin—testicular cancer	0.00117	0.00386	CcSEcCtD
Bepridil—Dizziness—Vinblastine—testicular cancer	0.00116	0.00384	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Ifosfamide—testicular cancer	0.00115	0.00381	CcSEcCtD
Bepridil—Myalgia—Cisplatin—testicular cancer	0.00114	0.00376	CcSEcCtD
Bepridil—Nausea—Chlorambucil—testicular cancer	0.00113	0.00376	CcSEcCtD
Bepridil—Paraesthesia—Ifosfamide—testicular cancer	0.00113	0.00376	CcSEcCtD
Bepridil—Anxiety—Cisplatin—testicular cancer	0.00113	0.00375	CcSEcCtD
Bepridil—Gastrointestinal pain—Dactinomycin—testicular cancer	0.00113	0.00374	CcSEcCtD
Bepridil—Dyspnoea—Ifosfamide—testicular cancer	0.00113	0.00373	CcSEcCtD
Bepridil—Somnolence—Ifosfamide—testicular cancer	0.00112	0.00372	CcSEcCtD
Bepridil—Liver function test abnormal—Methotrexate—testicular cancer	0.00112	0.00372	CcSEcCtD
Bepridil—Increased appetite—Doxorubicin—testicular cancer	0.00112	0.00371	CcSEcCtD
Bepridil—Vertigo—Etoposide—testicular cancer	0.0011	0.00364	CcSEcCtD
Bepridil—Decreased appetite—Ifosfamide—testicular cancer	0.0011	0.00364	CcSEcCtD
Bepridil—Headache—Vinblastine—testicular cancer	0.0011	0.00363	CcSEcCtD
Bepridil—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.00109	0.00361	CcSEcCtD
Bepridil—Abdominal pain—Dactinomycin—testicular cancer	0.00109	0.00361	CcSEcCtD
Bepridil—Body temperature increased—Dactinomycin—testicular cancer	0.00109	0.00361	CcSEcCtD
Bepridil—Oedema—Cisplatin—testicular cancer	0.00109	0.00361	CcSEcCtD
Bepridil—Pain—Ifosfamide—testicular cancer	0.00108	0.00358	CcSEcCtD
Bepridil—Constipation—Ifosfamide—testicular cancer	0.00108	0.00358	CcSEcCtD
Bepridil—Cardiac failure—Doxorubicin—testicular cancer	0.00108	0.00358	CcSEcCtD
Bepridil—Loss of consciousness—Etoposide—testicular cancer	0.00107	0.00356	CcSEcCtD
Bepridil—Cough—Etoposide—testicular cancer	0.00107	0.00354	CcSEcCtD
Bepridil—Asthenia—Bleomycin—testicular cancer	0.00106	0.00351	CcSEcCtD
Bepridil—Hypertension—Etoposide—testicular cancer	0.00106	0.0035	CcSEcCtD
Bepridil—Hyperhidrosis—Cisplatin—testicular cancer	0.00105	0.00349	CcSEcCtD
Bepridil—Liver function test abnormal—Epirubicin—testicular cancer	0.00105	0.00348	CcSEcCtD
Bepridil—Nausea—Vinblastine—testicular cancer	0.00104	0.00344	CcSEcCtD
Bepridil—Anorexia—Cisplatin—testicular cancer	0.00104	0.00344	CcSEcCtD
Bepridil—Gastrointestinal pain—Ifosfamide—testicular cancer	0.00103	0.00342	CcSEcCtD
Bepridil—Abdominal discomfort—Methotrexate—testicular cancer	0.00101	0.00334	CcSEcCtD
Bepridil—Gastritis—Epirubicin—testicular cancer	0.00101	0.00334	CcSEcCtD
Bepridil—Body temperature increased—Ifosfamide—testicular cancer	0.000998	0.00331	CcSEcCtD
Bepridil—Abdominal pain—Ifosfamide—testicular cancer	0.000998	0.00331	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.000992	0.00329	CcSEcCtD
Bepridil—Asthenia—Dactinomycin—testicular cancer	0.000989	0.00328	CcSEcCtD
Bepridil—Influenza—Epirubicin—testicular cancer	0.000983	0.00326	CcSEcCtD
Bepridil—Paraesthesia—Cisplatin—testicular cancer	0.000978	0.00324	CcSEcCtD
Bepridil—Liver function test abnormal—Doxorubicin—testicular cancer	0.000972	0.00322	CcSEcCtD
Bepridil—Dyspnoea—Cisplatin—testicular cancer	0.000971	0.00322	CcSEcCtD
Bepridil—Erectile dysfunction—Methotrexate—testicular cancer	0.000968	0.00321	CcSEcCtD
Bepridil—Hyperhidrosis—Etoposide—testicular cancer	0.000964	0.0032	CcSEcCtD
Bepridil—Angina pectoris—Epirubicin—testicular cancer	0.000958	0.00317	CcSEcCtD
Bepridil—Anorexia—Etoposide—testicular cancer	0.000951	0.00315	CcSEcCtD
Bepridil—Decreased appetite—Cisplatin—testicular cancer	0.000946	0.00314	CcSEcCtD
Bepridil—Diarrhoea—Dactinomycin—testicular cancer	0.000943	0.00313	CcSEcCtD
Bepridil—Gastrointestinal disorder—Cisplatin—testicular cancer	0.00094	0.00312	CcSEcCtD
Bepridil—Drowsiness—Methotrexate—testicular cancer	0.000937	0.00311	CcSEcCtD
Bepridil—Depression—Methotrexate—testicular cancer	0.000934	0.0031	CcSEcCtD
Bepridil—Rash—Bleomycin—testicular cancer	0.000932	0.00309	CcSEcCtD
Bepridil—Gastritis—Doxorubicin—testicular cancer	0.000931	0.00309	CcSEcCtD
Bepridil—Pain—Cisplatin—testicular cancer	0.000931	0.00309	CcSEcCtD
Bepridil—Dermatitis—Bleomycin—testicular cancer	0.000931	0.00309	CcSEcCtD
Bepridil—Influenza—Doxorubicin—testicular cancer	0.00091	0.00302	CcSEcCtD
Bepridil—Asthenia—Ifosfamide—testicular cancer	0.000906	0.003	CcSEcCtD
Bepridil—Sweating—Methotrexate—testicular cancer	0.000898	0.00298	CcSEcCtD
Bepridil—Paraesthesia—Etoposide—testicular cancer	0.000896	0.00297	CcSEcCtD
Bepridil—Dyspnoea—Etoposide—testicular cancer	0.000889	0.00295	CcSEcCtD
Bepridil—Somnolence—Etoposide—testicular cancer	0.000887	0.00294	CcSEcCtD
Bepridil—Angina pectoris—Doxorubicin—testicular cancer	0.000886	0.00294	CcSEcCtD
Bepridil—Nausea—Bleomycin—testicular cancer	0.000878	0.00291	CcSEcCtD
Bepridil—Drowsiness—Epirubicin—testicular cancer	0.000877	0.00291	CcSEcCtD
Bepridil—Rash—Dactinomycin—testicular cancer	0.000869	0.00288	CcSEcCtD
Bepridil—Decreased appetite—Etoposide—testicular cancer	0.000867	0.00287	CcSEcCtD
Bepridil—Diarrhoea—Ifosfamide—testicular cancer	0.000864	0.00286	CcSEcCtD
Bepridil—ABCB1—lymph node—testicular cancer	0.000862	0.00242	CbGeAlD
Bepridil—Gastrointestinal disorder—Etoposide—testicular cancer	0.000861	0.00285	CcSEcCtD
Bepridil—Body temperature increased—Cisplatin—testicular cancer	0.000861	0.00285	CcSEcCtD
Bepridil—Pain—Etoposide—testicular cancer	0.000853	0.00283	CcSEcCtD
Bepridil—Constipation—Etoposide—testicular cancer	0.000853	0.00283	CcSEcCtD
Bepridil—Sweating—Epirubicin—testicular cancer	0.00084	0.00279	CcSEcCtD
Bepridil—Dizziness—Ifosfamide—testicular cancer	0.000835	0.00277	CcSEcCtD
Bepridil—Pharyngitis—Methotrexate—testicular cancer	0.000835	0.00277	CcSEcCtD
Bepridil—Nausea—Dactinomycin—testicular cancer	0.000819	0.00271	CcSEcCtD
Bepridil—Gastrointestinal pain—Etoposide—testicular cancer	0.000816	0.0027	CcSEcCtD
Bepridil—Drowsiness—Doxorubicin—testicular cancer	0.000811	0.00269	CcSEcCtD
Bepridil—Bradycardia—Epirubicin—testicular cancer	0.000801	0.00266	CcSEcCtD
Bepridil—Rash—Ifosfamide—testicular cancer	0.000796	0.00264	CcSEcCtD
Bepridil—Dermatitis—Ifosfamide—testicular cancer	0.000795	0.00264	CcSEcCtD
Bepridil—Rhinitis—Epirubicin—testicular cancer	0.000789	0.00262	CcSEcCtD
Bepridil—Abdominal pain—Etoposide—testicular cancer	0.000788	0.00261	CcSEcCtD
Bepridil—Body temperature increased—Etoposide—testicular cancer	0.000788	0.00261	CcSEcCtD
Bepridil—Tinnitus—Methotrexate—testicular cancer	0.000784	0.0026	CcSEcCtD
Bepridil—Asthenia—Cisplatin—testicular cancer	0.000781	0.00259	CcSEcCtD
Bepridil—Pharyngitis—Epirubicin—testicular cancer	0.000781	0.00259	CcSEcCtD
Bepridil—Cardiac disorder—Methotrexate—testicular cancer	0.00078	0.00259	CcSEcCtD
Bepridil—Sweating—Doxorubicin—testicular cancer	0.000778	0.00258	CcSEcCtD
Bepridil—Nausea—Ifosfamide—testicular cancer	0.00075	0.00249	CcSEcCtD
Bepridil—Diarrhoea—Cisplatin—testicular cancer	0.000745	0.00247	CcSEcCtD
Bepridil—Bradycardia—Doxorubicin—testicular cancer	0.000741	0.00246	CcSEcCtD
Bepridil—Tinnitus—Epirubicin—testicular cancer	0.000734	0.00243	CcSEcCtD
Bepridil—Cardiac disorder—Epirubicin—testicular cancer	0.00073	0.00242	CcSEcCtD
Bepridil—Rhinitis—Doxorubicin—testicular cancer	0.00073	0.00242	CcSEcCtD
Bepridil—Pharyngitis—Doxorubicin—testicular cancer	0.000723	0.0024	CcSEcCtD
Bepridil—Asthenia—Etoposide—testicular cancer	0.000716	0.00237	CcSEcCtD
Bepridil—Arrhythmia—Epirubicin—testicular cancer	0.000703	0.00233	CcSEcCtD
Bepridil—Vision blurred—Methotrexate—testicular cancer	0.00069	0.00229	CcSEcCtD
Bepridil—Rash—Cisplatin—testicular cancer	0.000686	0.00228	CcSEcCtD
Bepridil—Dermatitis—Cisplatin—testicular cancer	0.000686	0.00227	CcSEcCtD
Bepridil—Diarrhoea—Etoposide—testicular cancer	0.000682	0.00226	CcSEcCtD
Bepridil—Tinnitus—Doxorubicin—testicular cancer	0.000679	0.00225	CcSEcCtD
Bepridil—Cardiac disorder—Doxorubicin—testicular cancer	0.000676	0.00224	CcSEcCtD
Bepridil—Flatulence—Epirubicin—testicular cancer	0.000675	0.00224	CcSEcCtD
Bepridil—Tension—Epirubicin—testicular cancer	0.000672	0.00223	CcSEcCtD
Bepridil—Nervousness—Epirubicin—testicular cancer	0.000665	0.00221	CcSEcCtD
Bepridil—Dizziness—Etoposide—testicular cancer	0.00066	0.00219	CcSEcCtD
Bepridil—Vertigo—Methotrexate—testicular cancer	0.000658	0.00218	CcSEcCtD
Bepridil—Arrhythmia—Doxorubicin—testicular cancer	0.00065	0.00216	CcSEcCtD
Bepridil—Nausea—Cisplatin—testicular cancer	0.000647	0.00214	CcSEcCtD
Bepridil—Vision blurred—Epirubicin—testicular cancer	0.000646	0.00214	CcSEcCtD
Bepridil—Cough—Methotrexate—testicular cancer	0.000639	0.00212	CcSEcCtD
Bepridil—Rash—Etoposide—testicular cancer	0.000629	0.00208	CcSEcCtD
Bepridil—Dermatitis—Etoposide—testicular cancer	0.000628	0.00208	CcSEcCtD
Bepridil—Headache—Etoposide—testicular cancer	0.000625	0.00207	CcSEcCtD
Bepridil—Flatulence—Doxorubicin—testicular cancer	0.000625	0.00207	CcSEcCtD
Bepridil—Myalgia—Methotrexate—testicular cancer	0.000623	0.00207	CcSEcCtD
Bepridil—Tension—Doxorubicin—testicular cancer	0.000622	0.00206	CcSEcCtD
Bepridil—Nervousness—Doxorubicin—testicular cancer	0.000616	0.00204	CcSEcCtD
Bepridil—Vertigo—Epirubicin—testicular cancer	0.000615	0.00204	CcSEcCtD
Bepridil—Syncope—Epirubicin—testicular cancer	0.000614	0.00204	CcSEcCtD
Bepridil—Palpitations—Epirubicin—testicular cancer	0.000605	0.00201	CcSEcCtD
Bepridil—Loss of consciousness—Epirubicin—testicular cancer	0.000602	0.002	CcSEcCtD
Bepridil—Cough—Epirubicin—testicular cancer	0.000598	0.00198	CcSEcCtD
Bepridil—Vision blurred—Doxorubicin—testicular cancer	0.000597	0.00198	CcSEcCtD
Bepridil—Nausea—Etoposide—testicular cancer	0.000592	0.00196	CcSEcCtD
Bepridil—Hypertension—Epirubicin—testicular cancer	0.000591	0.00196	CcSEcCtD
Bepridil—Myalgia—Epirubicin—testicular cancer	0.000583	0.00193	CcSEcCtD
Bepridil—Anxiety—Epirubicin—testicular cancer	0.000581	0.00193	CcSEcCtD
Bepridil—Hyperhidrosis—Methotrexate—testicular cancer	0.000578	0.00191	CcSEcCtD
Bepridil—Dry mouth—Epirubicin—testicular cancer	0.00057	0.00189	CcSEcCtD
Bepridil—Vertigo—Doxorubicin—testicular cancer	0.000569	0.00189	CcSEcCtD
Bepridil—Anorexia—Methotrexate—testicular cancer	0.000569	0.00189	CcSEcCtD
Bepridil—Syncope—Doxorubicin—testicular cancer	0.000568	0.00188	CcSEcCtD
Bepridil—Palpitations—Doxorubicin—testicular cancer	0.00056	0.00186	CcSEcCtD
Bepridil—Oedema—Epirubicin—testicular cancer	0.000559	0.00185	CcSEcCtD
Bepridil—Loss of consciousness—Doxorubicin—testicular cancer	0.000557	0.00185	CcSEcCtD
Bepridil—Cough—Doxorubicin—testicular cancer	0.000553	0.00183	CcSEcCtD
Bepridil—Shock—Epirubicin—testicular cancer	0.00055	0.00182	CcSEcCtD
Bepridil—Hypertension—Doxorubicin—testicular cancer	0.000547	0.00181	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000544	0.0018	CcSEcCtD
Bepridil—Hyperhidrosis—Epirubicin—testicular cancer	0.00054	0.00179	CcSEcCtD
Bepridil—Insomnia—Methotrexate—testicular cancer	0.00054	0.00179	CcSEcCtD
Bepridil—Myalgia—Doxorubicin—testicular cancer	0.00054	0.00179	CcSEcCtD
Bepridil—Anxiety—Doxorubicin—testicular cancer	0.000538	0.00178	CcSEcCtD
Bepridil—Paraesthesia—Methotrexate—testicular cancer	0.000536	0.00178	CcSEcCtD
Bepridil—Anorexia—Epirubicin—testicular cancer	0.000533	0.00177	CcSEcCtD
Bepridil—Dyspnoea—Methotrexate—testicular cancer	0.000533	0.00177	CcSEcCtD
Bepridil—Somnolence—Methotrexate—testicular cancer	0.000531	0.00176	CcSEcCtD
Bepridil—Dry mouth—Doxorubicin—testicular cancer	0.000528	0.00175	CcSEcCtD
Bepridil—Dyspepsia—Methotrexate—testicular cancer	0.000526	0.00174	CcSEcCtD
Bepridil—Decreased appetite—Methotrexate—testicular cancer	0.000519	0.00172	CcSEcCtD
Bepridil—Oedema—Doxorubicin—testicular cancer	0.000517	0.00171	CcSEcCtD
Bepridil—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000516	0.00171	CcSEcCtD
Bepridil—Pain—Methotrexate—testicular cancer	0.000511	0.00169	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000509	0.00169	CcSEcCtD
Bepridil—Shock—Doxorubicin—testicular cancer	0.000509	0.00169	CcSEcCtD
Bepridil—Insomnia—Epirubicin—testicular cancer	0.000506	0.00168	CcSEcCtD
Bepridil—CALM1—Downstream signal transduction—KITLG—testicular cancer	0.000504	0.00218	CbGpPWpGaD
Bepridil—Paraesthesia—Epirubicin—testicular cancer	0.000502	0.00166	CcSEcCtD
Bepridil—CALM2—Signaling by FGFR—KITLG—testicular cancer	0.000501	0.00217	CbGpPWpGaD
Bepridil—CALM1—Signaling by FGFR—KITLG—testicular cancer	0.000501	0.00217	CbGpPWpGaD
Bepridil—Hyperhidrosis—Doxorubicin—testicular cancer	0.0005	0.00166	CcSEcCtD
Bepridil—CACNA2D2—Metabolism—HPGDS—testicular cancer	0.0005	0.00217	CbGpPWpGaD
Bepridil—PDE1A—Immune System—BCL10—testicular cancer	0.0005	0.00217	CbGpPWpGaD
Bepridil—CALM1—Signaling by ERBB2—KITLG—testicular cancer	0.000499	0.00216	CbGpPWpGaD
Bepridil—CALM2—Signaling by ERBB2—KITLG—testicular cancer	0.000499	0.00216	CbGpPWpGaD
Bepridil—Dyspnoea—Epirubicin—testicular cancer	0.000498	0.00165	CcSEcCtD
Bepridil—Somnolence—Epirubicin—testicular cancer	0.000497	0.00165	CcSEcCtD
Bepridil—CALM2—DAP12 signaling—KITLG—testicular cancer	0.000496	0.00215	CbGpPWpGaD
Bepridil—CALM1—DAP12 signaling—KITLG—testicular cancer	0.000496	0.00215	CbGpPWpGaD
Bepridil—Anorexia—Doxorubicin—testicular cancer	0.000493	0.00163	CcSEcCtD
Bepridil—Dyspepsia—Epirubicin—testicular cancer	0.000492	0.00163	CcSEcCtD
Bepridil—Gastrointestinal pain—Methotrexate—testicular cancer	0.000489	0.00162	CcSEcCtD
Bepridil—Decreased appetite—Epirubicin—testicular cancer	0.000486	0.00161	CcSEcCtD
Bepridil—CALM3—DAP12 interactions—KITLG—testicular cancer	0.000483	0.00209	CbGpPWpGaD
Bepridil—CALM3—Signaling by FGFR in disease—KITLG—testicular cancer	0.000483	0.00209	CbGpPWpGaD
Bepridil—CALM3—Fc epsilon receptor (FCERI) signaling—KITLG—testicular cancer	0.000483	0.00209	CbGpPWpGaD
Bepridil—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000483	0.0016	CcSEcCtD
Bepridil—CACNA1H—Developmental Biology—MMP2—testicular cancer	0.000481	0.00209	CbGpPWpGaD
Bepridil—CALM3—Signaling by EGFR—KITLG—testicular cancer	0.000478	0.00207	CbGpPWpGaD
Bepridil—Pain—Epirubicin—testicular cancer	0.000478	0.00158	CcSEcCtD
Bepridil—Constipation—Epirubicin—testicular cancer	0.000478	0.00158	CcSEcCtD
Bepridil—CALM3—Signaling by EGFR in Cancer—KITLG—testicular cancer	0.000474	0.00206	CbGpPWpGaD
Bepridil—PDE1B—Innate Immune System—KITLG—testicular cancer	0.000473	0.00205	CbGpPWpGaD
Bepridil—Abdominal pain—Methotrexate—testicular cancer	0.000472	0.00157	CcSEcCtD
Bepridil—Body temperature increased—Methotrexate—testicular cancer	0.000472	0.00157	CcSEcCtD
Bepridil—CALM3—Signaling by PDGF—KITLG—testicular cancer	0.000472	0.00205	CbGpPWpGaD
Bepridil—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000471	0.00156	CcSEcCtD
Bepridil—Insomnia—Doxorubicin—testicular cancer	0.000468	0.00155	CcSEcCtD
Bepridil—CALM2—DAP12 interactions—KITLG—testicular cancer	0.000467	0.00202	CbGpPWpGaD
Bepridil—CALM2—Signaling by FGFR in disease—KITLG—testicular cancer	0.000467	0.00202	CbGpPWpGaD
Bepridil—CALM1—Signaling by FGFR in disease—KITLG—testicular cancer	0.000467	0.00202	CbGpPWpGaD
Bepridil—CALM1—DAP12 interactions—KITLG—testicular cancer	0.000467	0.00202	CbGpPWpGaD
Bepridil—CALM1—Fc epsilon receptor (FCERI) signaling—KITLG—testicular cancer	0.000467	0.00202	CbGpPWpGaD
Bepridil—CALM2—Fc epsilon receptor (FCERI) signaling—KITLG—testicular cancer	0.000467	0.00202	CbGpPWpGaD
Bepridil—CACNA1D—Axon guidance—MMP2—testicular cancer	0.000465	0.00201	CbGpPWpGaD
Bepridil—Paraesthesia—Doxorubicin—testicular cancer	0.000464	0.00154	CcSEcCtD
Bepridil—CALM2—Signaling by EGFR—KITLG—testicular cancer	0.000463	0.00201	CbGpPWpGaD
Bepridil—CALM1—Signaling by EGFR—KITLG—testicular cancer	0.000463	0.00201	CbGpPWpGaD
Bepridil—Dyspnoea—Doxorubicin—testicular cancer	0.000461	0.00153	CcSEcCtD
Bepridil—Somnolence—Doxorubicin—testicular cancer	0.00046	0.00152	CcSEcCtD
Bepridil—CALM1—Signaling by EGFR in Cancer—KITLG—testicular cancer	0.000459	0.00199	CbGpPWpGaD
Bepridil—CALM2—Signaling by EGFR in Cancer—KITLG—testicular cancer	0.000459	0.00199	CbGpPWpGaD
Bepridil—Gastrointestinal pain—Epirubicin—testicular cancer	0.000457	0.00152	CcSEcCtD
Bepridil—PDE1B—Immune System—BCL10—testicular cancer	0.000457	0.00198	CbGpPWpGaD
Bepridil—CALM1—Signaling by PDGF—KITLG—testicular cancer	0.000457	0.00198	CbGpPWpGaD
Bepridil—CALM2—Signaling by PDGF—KITLG—testicular cancer	0.000457	0.00198	CbGpPWpGaD
Bepridil—Dyspepsia—Doxorubicin—testicular cancer	0.000455	0.00151	CcSEcCtD
Bepridil—Decreased appetite—Doxorubicin—testicular cancer	0.00045	0.00149	CcSEcCtD
Bepridil—CALM3—B Cell Activation—KITLG—testicular cancer	0.000447	0.00194	CbGpPWpGaD
Bepridil—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000447	0.00148	CcSEcCtD
Bepridil—Pain—Doxorubicin—testicular cancer	0.000442	0.00147	CcSEcCtD
Bepridil—Constipation—Doxorubicin—testicular cancer	0.000442	0.00147	CcSEcCtD
Bepridil—Body temperature increased—Epirubicin—testicular cancer	0.000442	0.00147	CcSEcCtD
Bepridil—Abdominal pain—Epirubicin—testicular cancer	0.000442	0.00147	CcSEcCtD
Bepridil—CACNA1A—Metabolism—STK11—testicular cancer	0.000433	0.00188	CbGpPWpGaD
Bepridil—CALM1—B Cell Activation—KITLG—testicular cancer	0.000432	0.00187	CbGpPWpGaD
Bepridil—CALM2—B Cell Activation—KITLG—testicular cancer	0.000432	0.00187	CbGpPWpGaD
Bepridil—CALM3—RNF mutants show enhanced WNT signaling and proliferation—H2AFZ—testicular cancer	0.00043	0.00186	CbGpPWpGaD
Bepridil—Asthenia—Methotrexate—testicular cancer	0.000429	0.00142	CcSEcCtD
Bepridil—CALM3—NGF signalling via TRKA from the plasma membrane—KITLG—testicular cancer	0.000428	0.00185	CbGpPWpGaD
Bepridil—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000423	0.0014	CcSEcCtD
Bepridil—CALM1—RNF mutants show enhanced WNT signaling and proliferation—H2AFZ—testicular cancer	0.000416	0.0018	CbGpPWpGaD
Bepridil—CALM2—RNF mutants show enhanced WNT signaling and proliferation—H2AFZ—testicular cancer	0.000416	0.0018	CbGpPWpGaD
Bepridil—CALM1—NGF signalling via TRKA from the plasma membrane—KITLG—testicular cancer	0.000414	0.00179	CbGpPWpGaD
Bepridil—CALM2—NGF signalling via TRKA from the plasma membrane—KITLG—testicular cancer	0.000414	0.00179	CbGpPWpGaD
Bepridil—CALM3—Downstream signaling of activated FGFR—FGFR3—testicular cancer	0.000412	0.00178	CbGpPWpGaD
Bepridil—Body temperature increased—Doxorubicin—testicular cancer	0.000409	0.00136	CcSEcCtD
Bepridil—Abdominal pain—Doxorubicin—testicular cancer	0.000409	0.00136	CcSEcCtD
Bepridil—Diarrhoea—Methotrexate—testicular cancer	0.000409	0.00135	CcSEcCtD
Bepridil—CACNA1C—Axon guidance—MMP2—testicular cancer	0.000408	0.00177	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—INSL3—testicular cancer	0.000406	0.00176	CbGpPWpGaD
Bepridil—Asthenia—Epirubicin—testicular cancer	0.000401	0.00133	CcSEcCtD
Bepridil—CALM3—Signaling by WNT in cancer—H2AFZ—testicular cancer	0.000399	0.00173	CbGpPWpGaD
Bepridil—CALM2—Downstream signaling of activated FGFR—FGFR3—testicular cancer	0.000398	0.00173	CbGpPWpGaD
Bepridil—CALM1—Downstream signaling of activated FGFR—FGFR3—testicular cancer	0.000398	0.00173	CbGpPWpGaD
Bepridil—Dizziness—Methotrexate—testicular cancer	0.000395	0.00131	CcSEcCtD
Bepridil—CALM1—Signaling by GPCR—INSL3—testicular cancer	0.000393	0.0017	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—INSL3—testicular cancer	0.000393	0.0017	CbGpPWpGaD
Bepridil—CALM3—Downstream signal transduction—FGFR3—testicular cancer	0.000387	0.00168	CbGpPWpGaD
Bepridil—CALM2—Signaling by WNT in cancer—H2AFZ—testicular cancer	0.000386	0.00167	CbGpPWpGaD
Bepridil—CALM1—Signaling by WNT in cancer—H2AFZ—testicular cancer	0.000386	0.00167	CbGpPWpGaD
Bepridil—CALM3—Signaling by FGFR—FGFR3—testicular cancer	0.000385	0.00167	CbGpPWpGaD
Bepridil—PDE1A—Innate Immune System—FGFR3—testicular cancer	0.000384	0.00167	CbGpPWpGaD
Bepridil—CALM3—Signaling by ERBB2—FGFR3—testicular cancer	0.000383	0.00166	CbGpPWpGaD
Bepridil—Diarrhoea—Epirubicin—testicular cancer	0.000383	0.00127	CcSEcCtD
Bepridil—CALM3—DAP12 signaling—FGFR3—testicular cancer	0.000381	0.00165	CbGpPWpGaD
Bepridil—CALM3—Downstream signaling of activated FGFR—KIT—testicular cancer	0.000378	0.00164	CbGpPWpGaD
Bepridil—Rash—Methotrexate—testicular cancer	0.000377	0.00125	CcSEcCtD
Bepridil—Dermatitis—Methotrexate—testicular cancer	0.000376	0.00125	CcSEcCtD
Bepridil—CALM1—Downstream signal transduction—FGFR3—testicular cancer	0.000374	0.00162	CbGpPWpGaD
Bepridil—CALM2—Downstream signal transduction—FGFR3—testicular cancer	0.000374	0.00162	CbGpPWpGaD
Bepridil—Headache—Methotrexate—testicular cancer	0.000374	0.00124	CcSEcCtD
Bepridil—CALM2—Signaling by FGFR—FGFR3—testicular cancer	0.000373	0.00161	CbGpPWpGaD
Bepridil—CALM1—Signaling by FGFR—FGFR3—testicular cancer	0.000373	0.00161	CbGpPWpGaD
Bepridil—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—testicular cancer	0.000372	0.00161	CbGpPWpGaD
Bepridil—Asthenia—Doxorubicin—testicular cancer	0.000371	0.00123	CcSEcCtD
Bepridil—CALM1—Signaling by ERBB2—FGFR3—testicular cancer	0.000371	0.00161	CbGpPWpGaD
Bepridil—CALM2—Signaling by ERBB2—FGFR3—testicular cancer	0.000371	0.00161	CbGpPWpGaD
Bepridil—Dizziness—Epirubicin—testicular cancer	0.00037	0.00123	CcSEcCtD
Bepridil—CALM1—DAP12 signaling—FGFR3—testicular cancer	0.000369	0.0016	CbGpPWpGaD
Bepridil—CALM2—DAP12 signaling—FGFR3—testicular cancer	0.000369	0.0016	CbGpPWpGaD
Bepridil—CALM2—Downstream signaling of activated FGFR—KIT—testicular cancer	0.000366	0.00159	CbGpPWpGaD
Bepridil—CALM1—Downstream signaling of activated FGFR—KIT—testicular cancer	0.000366	0.00159	CbGpPWpGaD
Bepridil—CACNA2D2—Metabolism—STK11—testicular cancer	0.000363	0.00157	CbGpPWpGaD
Bepridil—CALM3—Signaling by FGFR in disease—FGFR3—testicular cancer	0.000359	0.00156	CbGpPWpGaD
Bepridil—CALM3—Fc epsilon receptor (FCERI) signaling—FGFR3—testicular cancer	0.000359	0.00156	CbGpPWpGaD
Bepridil—CALM3—DAP12 interactions—FGFR3—testicular cancer	0.000359	0.00156	CbGpPWpGaD
Bepridil—CALM3—Signaling by EGFR—FGFR3—testicular cancer	0.000356	0.00154	CbGpPWpGaD
Bepridil—CALM3—Downstream signal transduction—KIT—testicular cancer	0.000355	0.00154	CbGpPWpGaD
Bepridil—Nausea—Methotrexate—testicular cancer	0.000355	0.00118	CcSEcCtD
Bepridil—Diarrhoea—Doxorubicin—testicular cancer	0.000354	0.00117	CcSEcCtD
Bepridil—CALM3—Signaling by FGFR—KIT—testicular cancer	0.000354	0.00153	CbGpPWpGaD
Bepridil—PDE1A—Innate Immune System—KIT—testicular cancer	0.000353	0.00153	CbGpPWpGaD
Bepridil—Rash—Epirubicin—testicular cancer	0.000352	0.00117	CcSEcCtD
Bepridil—CALM3—Signaling by EGFR in Cancer—FGFR3—testicular cancer	0.000352	0.00153	CbGpPWpGaD
Bepridil—Dermatitis—Epirubicin—testicular cancer	0.000352	0.00117	CcSEcCtD
Bepridil—CALM3—Signaling by ERBB2—KIT—testicular cancer	0.000352	0.00153	CbGpPWpGaD
Bepridil—PDE1B—Innate Immune System—FGFR3—testicular cancer	0.000352	0.00152	CbGpPWpGaD
Bepridil—CALM3—Signaling by PDGF—FGFR3—testicular cancer	0.000351	0.00152	CbGpPWpGaD
Bepridil—Headache—Epirubicin—testicular cancer	0.00035	0.00116	CcSEcCtD
Bepridil—CALM3—DAP12 signaling—KIT—testicular cancer	0.00035	0.00152	CbGpPWpGaD
Bepridil—CALM2—Fc epsilon receptor (FCERI) signaling—FGFR3—testicular cancer	0.000347	0.0015	CbGpPWpGaD
Bepridil—CALM2—DAP12 interactions—FGFR3—testicular cancer	0.000347	0.0015	CbGpPWpGaD
Bepridil—CALM1—DAP12 interactions—FGFR3—testicular cancer	0.000347	0.0015	CbGpPWpGaD
Bepridil—CALM1—Fc epsilon receptor (FCERI) signaling—FGFR3—testicular cancer	0.000347	0.0015	CbGpPWpGaD
Bepridil—CALM2—Signaling by FGFR in disease—FGFR3—testicular cancer	0.000347	0.0015	CbGpPWpGaD
Bepridil—CALM1—Signaling by FGFR in disease—FGFR3—testicular cancer	0.000347	0.0015	CbGpPWpGaD
Bepridil—CALM2—Signaling by EGFR—FGFR3—testicular cancer	0.000344	0.00149	CbGpPWpGaD
Bepridil—CALM1—Signaling by EGFR—FGFR3—testicular cancer	0.000344	0.00149	CbGpPWpGaD
Bepridil—CALM2—Downstream signal transduction—KIT—testicular cancer	0.000344	0.00149	CbGpPWpGaD
Bepridil—CALM1—Downstream signal transduction—KIT—testicular cancer	0.000344	0.00149	CbGpPWpGaD
Bepridil—CALM2—Signaling by FGFR—KIT—testicular cancer	0.000342	0.00148	CbGpPWpGaD
Bepridil—CALM1—Signaling by FGFR—KIT—testicular cancer	0.000342	0.00148	CbGpPWpGaD
Bepridil—Dizziness—Doxorubicin—testicular cancer	0.000342	0.00113	CcSEcCtD
Bepridil—CALM2—Signaling by EGFR in Cancer—FGFR3—testicular cancer	0.000341	0.00148	CbGpPWpGaD
Bepridil—CALM1—Signaling by EGFR in Cancer—FGFR3—testicular cancer	0.000341	0.00148	CbGpPWpGaD
Bepridil—CALM2—Signaling by ERBB2—KIT—testicular cancer	0.00034	0.00148	CbGpPWpGaD
Bepridil—CALM1—Signaling by ERBB2—KIT—testicular cancer	0.00034	0.00148	CbGpPWpGaD
Bepridil—CALM1—Signaling by PDGF—FGFR3—testicular cancer	0.000339	0.00147	CbGpPWpGaD
Bepridil—CALM2—Signaling by PDGF—FGFR3—testicular cancer	0.000339	0.00147	CbGpPWpGaD
Bepridil—CALM1—DAP12 signaling—KIT—testicular cancer	0.000339	0.00147	CbGpPWpGaD
Bepridil—CALM2—DAP12 signaling—KIT—testicular cancer	0.000339	0.00147	CbGpPWpGaD
Bepridil—CALM3—B Cell Activation—FGFR3—testicular cancer	0.000332	0.00144	CbGpPWpGaD
Bepridil—Nausea—Epirubicin—testicular cancer	0.000332	0.0011	CcSEcCtD
Bepridil—CACNA1D—Developmental Biology—MMP2—testicular cancer	0.000332	0.00144	CbGpPWpGaD
Bepridil—CALM3—Fc epsilon receptor (FCERI) signaling—KIT—testicular cancer	0.000329	0.00143	CbGpPWpGaD
Bepridil—CALM3—DAP12 interactions—KIT—testicular cancer	0.000329	0.00143	CbGpPWpGaD
Bepridil—CALM3—Signaling by FGFR in disease—KIT—testicular cancer	0.000329	0.00143	CbGpPWpGaD
Bepridil—CALM3—Signaling by Wnt—H2AFZ—testicular cancer	0.000329	0.00143	CbGpPWpGaD
Bepridil—CALM3—Signaling by NGF—KITLG—testicular cancer	0.000329	0.00143	CbGpPWpGaD
Bepridil—CALM3—Signaling by EGFR—KIT—testicular cancer	0.000327	0.00142	CbGpPWpGaD
Bepridil—Rash—Doxorubicin—testicular cancer	0.000326	0.00108	CcSEcCtD
Bepridil—Dermatitis—Doxorubicin—testicular cancer	0.000326	0.00108	CcSEcCtD
Bepridil—CACNA1D—Metabolism—HPGDS—testicular cancer	0.000324	0.00141	CbGpPWpGaD
Bepridil—Headache—Doxorubicin—testicular cancer	0.000324	0.00107	CcSEcCtD
Bepridil—CALM3—Signaling by EGFR in Cancer—KIT—testicular cancer	0.000324	0.0014	CbGpPWpGaD
Bepridil—PDE1B—Innate Immune System—KIT—testicular cancer	0.000323	0.0014	CbGpPWpGaD
Bepridil—CALM3—Signaling by PDGF—KIT—testicular cancer	0.000322	0.0014	CbGpPWpGaD
Bepridil—CALM2—B Cell Activation—FGFR3—testicular cancer	0.000321	0.00139	CbGpPWpGaD
Bepridil—CALM1—B Cell Activation—FGFR3—testicular cancer	0.000321	0.00139	CbGpPWpGaD
Bepridil—CALM2—DAP12 interactions—KIT—testicular cancer	0.000319	0.00138	CbGpPWpGaD
Bepridil—CALM1—Fc epsilon receptor (FCERI) signaling—KIT—testicular cancer	0.000319	0.00138	CbGpPWpGaD
Bepridil—CALM2—Signaling by FGFR in disease—KIT—testicular cancer	0.000319	0.00138	CbGpPWpGaD
Bepridil—CALM1—DAP12 interactions—KIT—testicular cancer	0.000319	0.00138	CbGpPWpGaD
Bepridil—CALM1—Signaling by FGFR in disease—KIT—testicular cancer	0.000319	0.00138	CbGpPWpGaD
Bepridil—CALM2—Fc epsilon receptor (FCERI) signaling—KIT—testicular cancer	0.000319	0.00138	CbGpPWpGaD
Bepridil—CALM1—Signaling by Wnt—H2AFZ—testicular cancer	0.000319	0.00138	CbGpPWpGaD
Bepridil—CALM2—Signaling by Wnt—H2AFZ—testicular cancer	0.000319	0.00138	CbGpPWpGaD
Bepridil—CALM2—Signaling by NGF—KITLG—testicular cancer	0.000318	0.00138	CbGpPWpGaD
Bepridil—CALM1—Signaling by NGF—KITLG—testicular cancer	0.000318	0.00138	CbGpPWpGaD
Bepridil—CALM3—NGF signalling via TRKA from the plasma membrane—FGFR3—testicular cancer	0.000318	0.00138	CbGpPWpGaD
Bepridil—CALM2—Signaling by EGFR—KIT—testicular cancer	0.000316	0.00137	CbGpPWpGaD
Bepridil—CALM1—Signaling by EGFR—KIT—testicular cancer	0.000316	0.00137	CbGpPWpGaD
Bepridil—CALM2—Signaling by EGFR in Cancer—KIT—testicular cancer	0.000313	0.00136	CbGpPWpGaD
Bepridil—CALM1—Signaling by EGFR in Cancer—KIT—testicular cancer	0.000313	0.00136	CbGpPWpGaD
Bepridil—CALM1—Signaling by PDGF—KIT—testicular cancer	0.000312	0.00135	CbGpPWpGaD
Bepridil—CALM2—Signaling by PDGF—KIT—testicular cancer	0.000312	0.00135	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—BCL10—testicular cancer	0.000311	0.00135	CbGpPWpGaD
Bepridil—CALM2—NGF signalling via TRKA from the plasma membrane—FGFR3—testicular cancer	0.000307	0.00133	CbGpPWpGaD
Bepridil—CALM1—NGF signalling via TRKA from the plasma membrane—FGFR3—testicular cancer	0.000307	0.00133	CbGpPWpGaD
Bepridil—Nausea—Doxorubicin—testicular cancer	0.000307	0.00102	CcSEcCtD
Bepridil—CALM3—B Cell Activation—KIT—testicular cancer	0.000305	0.00132	CbGpPWpGaD
Bepridil—PDE1A—Disease—H2AFZ—testicular cancer	0.000302	0.00131	CbGpPWpGaD
Bepridil—PDE1A—Immune System—KITLG—testicular cancer	0.000301	0.00131	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—BCL10—testicular cancer	0.000301	0.0013	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—BCL10—testicular cancer	0.000301	0.0013	CbGpPWpGaD
Bepridil—CALM3—Adaptive Immune System—BCL10—testicular cancer	0.000299	0.00129	CbGpPWpGaD
Bepridil—CALM2—B Cell Activation—KIT—testicular cancer	0.000295	0.00128	CbGpPWpGaD
Bepridil—CALM1—B Cell Activation—KIT—testicular cancer	0.000295	0.00128	CbGpPWpGaD
Bepridil—CALM3—NGF signalling via TRKA from the plasma membrane—KIT—testicular cancer	0.000292	0.00126	CbGpPWpGaD
Bepridil—CACNA1C—Developmental Biology—MMP2—testicular cancer	0.000291	0.00126	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—BCL10—testicular cancer	0.000289	0.00125	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—BCL10—testicular cancer	0.000289	0.00125	CbGpPWpGaD
Bepridil—CACNA1C—Metabolism—HPGDS—testicular cancer	0.000285	0.00124	CbGpPWpGaD
Bepridil—CALM1—NGF signalling via TRKA from the plasma membrane—KIT—testicular cancer	0.000282	0.00122	CbGpPWpGaD
Bepridil—CALM2—NGF signalling via TRKA from the plasma membrane—KIT—testicular cancer	0.000282	0.00122	CbGpPWpGaD
Bepridil—PDE1A—Disease—KITLG—testicular cancer	0.000278	0.00121	CbGpPWpGaD
Bepridil—PDE1B—Disease—H2AFZ—testicular cancer	0.000277	0.0012	CbGpPWpGaD
Bepridil—PDE1B—Immune System—KITLG—testicular cancer	0.000276	0.00119	CbGpPWpGaD
Bepridil—PDE1B—Disease—KITLG—testicular cancer	0.000254	0.0011	CbGpPWpGaD
Bepridil—CALM3—Signaling by NGF—FGFR3—testicular cancer	0.000244	0.00106	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—INSL3—testicular cancer	0.00024	0.00104	CbGpPWpGaD
Bepridil—CALM2—Signaling by NGF—FGFR3—testicular cancer	0.000236	0.00102	CbGpPWpGaD
Bepridil—CALM1—Signaling by NGF—FGFR3—testicular cancer	0.000236	0.00102	CbGpPWpGaD
Bepridil—CACNA1D—Metabolism—STK11—testicular cancer	0.000236	0.00102	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—INSL3—testicular cancer	0.000232	0.00101	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—INSL3—testicular cancer	0.000232	0.00101	CbGpPWpGaD
Bepridil—CALM3—Signaling by NGF—KIT—testicular cancer	0.000224	0.000973	CbGpPWpGaD
Bepridil—PDE1A—Immune System—FGFR3—testicular cancer	0.000224	0.000971	CbGpPWpGaD
Bepridil—CALM2—Signaling by NGF—KIT—testicular cancer	0.000217	0.000941	CbGpPWpGaD
Bepridil—CALM1—Signaling by NGF—KIT—testicular cancer	0.000217	0.000941	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—H2AFZ—testicular cancer	0.000212	0.000918	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—STK11—testicular cancer	0.000211	0.000913	CbGpPWpGaD
Bepridil—CACNA1C—Metabolism—STK11—testicular cancer	0.000207	0.000898	CbGpPWpGaD
Bepridil—PDE1A—Disease—FGFR3—testicular cancer	0.000207	0.000896	CbGpPWpGaD
Bepridil—PDE1A—Immune System—KIT—testicular cancer	0.000206	0.000891	CbGpPWpGaD
Bepridil—PDE1B—Immune System—FGFR3—testicular cancer	0.000205	0.000888	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—KITLG—testicular cancer	0.000195	0.000844	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—H2AFZ—testicular cancer	0.000194	0.000839	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—STK11—testicular cancer	0.000193	0.000835	CbGpPWpGaD
Bepridil—PDE1A—Disease—KIT—testicular cancer	0.00019	0.000823	CbGpPWpGaD
Bepridil—PDE1B—Disease—FGFR3—testicular cancer	0.000189	0.00082	CbGpPWpGaD
Bepridil—PDE1B—Immune System—KIT—testicular cancer	0.000188	0.000815	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—KITLG—testicular cancer	0.000188	0.000813	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—KITLG—testicular cancer	0.000181	0.000787	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—KITLG—testicular cancer	0.000181	0.000787	CbGpPWpGaD
Bepridil—CALM3—Immune System—BCL10—testicular cancer	0.000181	0.000785	CbGpPWpGaD
Bepridil—CALM3—Adaptive Immune System—KITLG—testicular cancer	0.00018	0.000781	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—KITLG—testicular cancer	0.000178	0.000772	CbGpPWpGaD
Bepridil—CALM2—Immune System—BCL10—testicular cancer	0.000175	0.00076	CbGpPWpGaD
Bepridil—CALM1—Immune System—BCL10—testicular cancer	0.000175	0.00076	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—KITLG—testicular cancer	0.000174	0.000755	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—KITLG—testicular cancer	0.000174	0.000755	CbGpPWpGaD
Bepridil—PDE1B—Disease—KIT—testicular cancer	0.000174	0.000752	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—FGFR3—testicular cancer	0.000145	0.000628	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—FGFR3—testicular cancer	0.000139	0.000604	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—FGFR3—testicular cancer	0.000135	0.000585	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—FGFR3—testicular cancer	0.000135	0.000585	CbGpPWpGaD
Bepridil—CALM3—Adaptive Immune System—FGFR3—testicular cancer	0.000134	0.00058	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—KIT—testicular cancer	0.000133	0.000576	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—FGFR3—testicular cancer	0.000132	0.000574	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—FGFR3—testicular cancer	0.00013	0.000561	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—FGFR3—testicular cancer	0.00013	0.000561	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—KIT—testicular cancer	0.000128	0.000555	CbGpPWpGaD
Bepridil—CALM3—Metabolism—HPGDS—testicular cancer	0.000126	0.000545	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—KIT—testicular cancer	0.000124	0.000537	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—KIT—testicular cancer	0.000124	0.000537	CbGpPWpGaD
Bepridil—CALM3—Adaptive Immune System—KIT—testicular cancer	0.000123	0.000533	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—KIT—testicular cancer	0.000122	0.000527	CbGpPWpGaD
Bepridil—CALM1—Metabolism—HPGDS—testicular cancer	0.000122	0.000527	CbGpPWpGaD
Bepridil—CALM2—Metabolism—HPGDS—testicular cancer	0.000122	0.000527	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—KIT—testicular cancer	0.000119	0.000515	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—KIT—testicular cancer	0.000119	0.000515	CbGpPWpGaD
Bepridil—CALM3—Disease—H2AFZ—testicular cancer	0.00011	0.000475	CbGpPWpGaD
Bepridil—CALM3—Immune System—KITLG—testicular cancer	0.000109	0.000474	CbGpPWpGaD
Bepridil—CALM1—Disease—H2AFZ—testicular cancer	0.000106	0.00046	CbGpPWpGaD
Bepridil—CALM2—Disease—H2AFZ—testicular cancer	0.000106	0.00046	CbGpPWpGaD
Bepridil—CALM2—Immune System—KITLG—testicular cancer	0.000106	0.000458	CbGpPWpGaD
Bepridil—CALM1—Immune System—KITLG—testicular cancer	0.000106	0.000458	CbGpPWpGaD
Bepridil—CALM3—Disease—KITLG—testicular cancer	0.000101	0.000437	CbGpPWpGaD
Bepridil—CALM2—Disease—KITLG—testicular cancer	9.76e-05	0.000423	CbGpPWpGaD
Bepridil—CALM1—Disease—KITLG—testicular cancer	9.76e-05	0.000423	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—HPGDS—testicular cancer	9.52e-05	0.000413	CbGpPWpGaD
Bepridil—CALM3—Metabolism—STK11—testicular cancer	9.13e-05	0.000396	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—HPGDS—testicular cancer	8.97e-05	0.000389	CbGpPWpGaD
Bepridil—CALM2—Metabolism—STK11—testicular cancer	8.83e-05	0.000383	CbGpPWpGaD
Bepridil—CALM1—Metabolism—STK11—testicular cancer	8.83e-05	0.000383	CbGpPWpGaD
Bepridil—CALM3—Immune System—FGFR3—testicular cancer	8.12e-05	0.000352	CbGpPWpGaD
Bepridil—CALM2—Immune System—FGFR3—testicular cancer	7.86e-05	0.00034	CbGpPWpGaD
Bepridil—CALM1—Immune System—FGFR3—testicular cancer	7.86e-05	0.00034	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—H2AFZ—testicular cancer	7.68e-05	0.000333	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—STK11—testicular cancer	7.63e-05	0.000331	CbGpPWpGaD
Bepridil—CALM3—Disease—FGFR3—testicular cancer	7.5e-05	0.000325	CbGpPWpGaD
Bepridil—CALM3—Immune System—KIT—testicular cancer	7.46e-05	0.000323	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—H2AFZ—testicular cancer	7.43e-05	0.000322	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—H2AFZ—testicular cancer	7.43e-05	0.000322	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—STK11—testicular cancer	7.39e-05	0.00032	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—STK11—testicular cancer	7.39e-05	0.00032	CbGpPWpGaD
Bepridil—CALM2—Disease—FGFR3—testicular cancer	7.25e-05	0.000314	CbGpPWpGaD
Bepridil—CALM1—Disease—FGFR3—testicular cancer	7.25e-05	0.000314	CbGpPWpGaD
Bepridil—CALM2—Immune System—KIT—testicular cancer	7.21e-05	0.000313	CbGpPWpGaD
Bepridil—CALM1—Immune System—KIT—testicular cancer	7.21e-05	0.000313	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—KITLG—testicular cancer	7.06e-05	0.000306	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—STK11—testicular cancer	6.92e-05	0.0003	CbGpPWpGaD
Bepridil—CALM3—Disease—KIT—testicular cancer	6.88e-05	0.000298	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—KITLG—testicular cancer	6.83e-05	0.000296	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—KITLG—testicular cancer	6.83e-05	0.000296	CbGpPWpGaD
Bepridil—CALM2—Disease—KIT—testicular cancer	6.66e-05	0.000289	CbGpPWpGaD
Bepridil—CALM1—Disease—KIT—testicular cancer	6.66e-05	0.000289	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—STK11—testicular cancer	6.52e-05	0.000283	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—FGFR3—testicular cancer	5.25e-05	0.000228	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—FGFR3—testicular cancer	5.08e-05	0.00022	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—FGFR3—testicular cancer	5.08e-05	0.00022	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—KIT—testicular cancer	4.82e-05	0.000209	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—KIT—testicular cancer	4.66e-05	0.000202	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—KIT—testicular cancer	4.66e-05	0.000202	CbGpPWpGaD
